Sanjiv S. Gambhir

Sanjiv S. Gambhir

Stanford University

H-index: 162

North America-United States

Professor Information

University

Stanford University

Position

Professor of Radiology

Citations(all)

108924

Citations(since 2020)

32286

Cited By

89812

hIndex(all)

162

hIndex(since 2020)

83

i10Index(all)

727

i10Index(since 2020)

478

Email

University Profile Page

Stanford University

Research & Interests List

molecular imaging

positron emission tomography

nuclear medicine

early cancer detection

Top articles of Sanjiv S. Gambhir

Supplementary file

6 Hidalgo‐Lozano A, Fernández‐de‐las‐Peñas C, Alonso‐Blanco C, et al. Muscle trigger points and pressure pain hyperalgesia in the shoulder muscles in patients with unilateral shoulder impingement: a blinded, controlled study. Exp Brain Res 2010; 202: 915–25. doi: 10.1007/s00221‐010‐2196‐47 Clausen MB, Bandholm T, Rathleff MS, et al. The Strengthening Exercises in Shoulder Impingement trial (The SExSI‐trial) investigating the effectiveness of a simple add‐on shoulder strengthening exercise programme in patients with long‐lasting subacromial impingement syndrome: Study protocol for a pragmatic, assessor blinded, parallel‐group, randomised, controlled trial. Trials 2018; 19: 154. doi: 10.1186/s13063‐018‐2509‐7

Authors

MB Clausen,MS Rathleff,MB Clausen

Journal

Br J Sports Med

Published Date

2023

Circulating tumor cell diagnostics for lung cancer

The present invention provides methods for diagnosing lung cancer in a subject comprising (a) generating circulating tumor cell (CTC) data from a blood sample obtained from the subject based on a direct analysis comprising immunofluorescent staining and morphological characteristics of nucleated cells in the sample, wherein CTCs are identified in context of surrounding nucleated cells based on a combination of the immunofluorescent staining and morphological characteristics;(b) obtaining clinical data for the subject;(c) combining the CTC data with the clinical data to diagnose lung cancer in the subject.

Published Date

2021/4/15

Highly Excretable Gold Supraclusters for Translatable In Vivo Raman Imaging of Tumors

Raman spectroscopy provides excellent specificity for in vivo preclinical imaging through a readout of fingerprint-like spectra. To achieve sufficient sensitivity for in vivo Raman imaging, metallic gold nanoparticles larger than 10 nm were employed to amplify Raman signals via surface-enhanced Raman scattering (SERS). However, the inability to excrete such large gold nanoparticles has restricted the translation of Raman imaging. Here we present Raman-active metallic gold supraclusters that are biodegradable and excretable as nanoclusters. Although the small size of the gold nanocluster building blocks compromises the electromagnetic field enhancement effect, the supraclusters exhibit bright and prominent Raman scattering comparable to that of large gold nanoparticle-based SERS nanotags due to high loading of NIR-resonant Raman dyes and much suppressed fluorescence background by metallic …

Authors

Jung Ho Yu,Myeong Seon Jeong,Emma Olivia Cruz,Israt S Alam,Spencer K Tumbale,Aimen Zlitni,Song Yeul Lee,Yong Il Park,Katherine Ferrara,Seung-Hae Kwon,Sanjiv S Gambhir,Jianghong Rao

Journal

ACS nano

Published Date

2023/1/23

Exosome-total-isolation-chip (ExoTIC) device for isolation of exosome-based biomarkers

A device (“the ExoTIC device”) for the isolation of extracellular vesicles from an extracellular vesicle-containing sample in which the sample is flowed through a membrane in a flow chamber to capture and purify the extracellular vesicles on the membrane. The extracellular vesicles may be washed and collected and utilized in any one of a number of ways including, but not limited to, identifying biomarkers of a disease, identifying the presence of a biomarker in a patient to determine whether a patient has a disease, and therapeutically treating existing diseases by re-introducing the extracellular vesicles, potentially modified, back into a body.

Published Date

2023/9/19

A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy

Although literature suggests that resistance to TNF inhibitor (TNFi) therapy in patients with ulcerative colitis (UC) is partially linked to immune cell populations in the inflamed region, there is still substantial uncertainty underlying the relevant spatial context. Here, we used the highly multiplexed immunofluorescence imaging technology CODEX to create a publicly browsable tissue atlas of inflammation in 42 tissue regions from 29 patients with UC and 5 healthy individuals. We analyzed 52 biomarkers on 1,710,973 spatially resolved single cells to determine cell types, cell-cell contacts, and cellular neighborhoods. We observed that cellular functional states are associated with cellular neighborhoods. We further observed that a subset of inflammatory cell types and cellular neighborhoods are present in patients with UC with TNFi treatment, potentially indicating resistant niches. Last, we explored applying convolutional …

Authors

Aaron T Mayer,Derek R Holman,Anav Sood,Utkarsh Tandon,Salil S Bhate,Sunil Bodapati,Graham L Barlow,Jeff Chang,Sarah Black,Erica C Crenshaw,Alexander N Koron,Sarah E Streett,Sanjiv S Gambhir,William J Sandborn,Brigid S Boland,Trevor Hastie,Robert Tibshirani,John T Chang,Garry P Nolan,Christian M Schürch,Stephan Rogalla

Journal

Science advances

Published Date

2023/1/20

Correction to “Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents”

As published previously, in Figure 7c− e, we had inadvertently and erroneously repeated the same images twice in panels c and e while missing an image for day 12 in panel d. We now include the correct images in the panels. The other components of

Authors

Rajendran JC Bose,Sukumar Uday Kumar,Yitian Zeng,Rayhaneh Afjei,Elise Robinson,Kenneth Lau,Abel Bermudez,Frezghi Habte,Sharon J Pitteri,Robert Sinclair,Juergen K Willmann,Tarik F Massoud,Sanjiv S Gambhir,Ramasamy Paulmurugan

Journal

ACS nano

Published Date

2023/9/18

Correction to “SP94-Targeted Triblock Copolymer Nanoparticle Delivers Thymidine Kinase–p53–Nitroreductase Triple Therapeutic Gene and Restores Anticancer Function against …

In the original version of our paper (https://pubs. acs. org/ doi/10.1021/acsami. 9b20071), Figure 6 f shows the magnified images of H&E stained kidney tissues for both TK− NTR− SP94 and TK− p53− NTR conditions that were inadvertently and erroneously taken from the same TK− p53− NTR slide. The correct images are shown here. Figure 6 a− e) are correct as published previously. There is no change made to the figure legend. This error does not change the fundamental nature or message of our findings.

Authors

Uday K Sukumar,Jagathesh Chandra Bose Rajendran,Sanjiv S Gambhir,Tarik F Massoud,Ramasamy Paulmurugan

Journal

ACS Applied Materials & Interfaces

Published Date

2023/8/22

FDTD simulation and chemical synthesis of surface-enhanced Raman supraparticles for translatable in vivo Raman imaging (Conference Presentation)

Surface-enhanced Raman scattering (SERS) has extended its biomedical application to in vivo preclinical imaging. However, the in vivo SERS imaging requires non-clearable large gold nanoparticles, limiting their translation in humans. Here, we address this problem by creating SERS supraparticles composed of small-sized nanoclusters. First, we performed the FDTD simulation of the supraparticle design, and the maximum enhancement factor of 10^6 was achieved. Second, we chemically synthesized bright supraparticles that enabled in vivo Raman imaging of rodent models. Furthermore, the supraparticles were highly excretable, offering great potential for clinical application of in vivo Raman imaging by replacing non-excretable SERS nanotags.

Authors

Jung Ho Yu,Emma O Cruz,Sanjiv S Gambhir

Published Date

2023/3/16

academic-engine

Useful Links